All Stories

  1. Identification and characterization of tweets related to the 2015 Indiana HIV outbreak: A retrospective infoveillance study
  2. An Interdisciplinary Review of Surgical Data Recording Technology Features and Legal Considerations
  3. Opioids and the Internet: Convergence of Technology and Policy to Address the Illicit Online Sales of Opioids
  4. Detection of illicit online sales of fentanyls via Twitter
  5. A review of existing and emerging digital technologies to combat the global trade in fake medicines
  6. USA Criminal and Civil Prosecutions Associated with Illicit Online Pharmacies: Legal Analysis and Global Implications
  7. Emerging and Reemerging Neglected Tropical Diseases: a Review of Key Characteristics, Risk Factors, and the Policy and Innovation Environment
  8. Prescription drug coupons: Evolution and need for regulation in direct-to-consumer advertising
  9. Health Domains for Sale: The Need for Global Health Internet Governance
  10. The Minamata Convention on Mercury: Attempting to address the global controversy of dental amalgam use and mercury waste disposal
  11. Policy Review: Japan–Philippines Economic Partnership Agreement (JPEPA)—Analysis of a failed nurse migration policy
  12. Why the MDGs need good governance in pharmaceutical systems to promote global health
  13. Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism
  14. Dangerous Science: Online Promotion of Unproven Stem Cell Therapies and Global Health Risks
  15. Technology and Medicine: Academic Dishonesty and Risks to Global Health
  16. Reply to Stanback et al.'s “Suspect Online Sellers and Contraceptive Access”
  17. Ensuring the future of health information online
  18. Digital Social Media, Youth, and Nonmedical Use of Prescription Drugs: The Need for Reform
  19. Global Reach of Direct-to-Consumer Advertising Using Social Media for Illicit Online Drug Sales
  20. Illicit online marketing of lorcaserin before DEA scheduling
  21. Illegal “No Prescription” Internet Access to Narrow Therapeutic Index Drugs
  22. Evolution of Tobacco Labeling and Packaging: International Legal Considerations and Health Governance
  23. Online Availability and Safety of Drugs in Shortage
  24. Restructuring brain drain: strengthening governance and financing for health worker migration
  25. A United Nations Global Health Panel for Global Health Governance
  26. Response to comments on “A United Nations Global Health Panel for Global Health Governance”
  27. Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health
  28. Promoting global health: utilizing WHO to integrate public health, innovation and intellectual property
  29. Patent and Exclusivity Status of Essential Medicines for Non-Communicable Disease
  30. Suspect online sellers and contraceptive access
  31. Combating healthcare corruption and fraud with improved global health governance
  32. Globalization, Evolution and Emergence of Direct-to-Consumer Advertising: Are Emerging Markets the Next Pharmaceutical Marketing Frontier?
  33. Rebalancing brain drain: Exploring resource reallocation to address health worker migration and promote global health
  34. Separating online piracy from counterfeit medicines: The need for policy reform and a call to action
  35. Threats from emerging and re-emerging neglected tropical diseases (NTDs)
  36. Global health policy coordination to address neglected tropical diseases
  37. Online risks to health—the problem of counterfeit drugs
  38. Integrating Biodiversity Management and Indigenous Biopiracy Protection to Promote Environmental Justice and Global Health
  39. Promoting access to biosimilars: a public−private partnership model for biosimilar development in underserved populations
  40. Waking Up to the Risks of Online Direct-to-Consumer Advertising of Sleep Apnea Screening Tests
  41. Online Availability and Safety of Drugs in Shortage: A Descriptive Study of Internet Vendor Characteristics
  42. Elder Abuse
  43. Emerging Dangers from Direct Botulinum Access and Use
  44. Transparency in Physician-Industry Relationships
  45. Vaccine shortages and suspect online pharmacy sellers
  46. Emerging patient safety issues under health care reform: follow-on biologics and immunogenicity
  47. Preparing for Health Diplomacy Negotiations — Global Governance and the Case of Taiwan, WHO, and SARS
  48. Lessons from SARS and H1N1/A: Employing a WHO–WTO forum to promote optimal economic-public health pandemic response
  49. The global counterfeit drug trade: Patient safety and public health risks
  50. Quality and Safety in Medical Care: What Does the Future Hold?
  51. Prevalence and Global Health Implications of Social Media in Direct-to-Consumer Drug Advertising
  52. Promoting online drug safety: Using public–private partnerships to deter illicit online drug sales
  53. Reforming direct-to-consumer advertising
  54. Direct-to-Consumer Advertising With Interactive Internet Media
  55. eHealth Ethics: The Online Medical Marketplace and Emerging Ethical Issues
  56. The Role of Practice Guidelines in Medical Malpractice Litigation
  57. Reforming Off-Label Promotion to Enhance Orphan Disease Treatment